Concepedia

Alberto Pietropoli

AP

10

Publications

253

Citations

10

H-Index

2003

Active since

Affiliations

Novo Nordisk (Switzerland)(Current)

Novo Nordisk (United States)

Saarland University

Cincinnati Children's Hospital Medical Center

University of Cincinnati

Alberto Pietropoli is an author at Novo Nordisk (Switzerland) specializing in medicine, human growth, and health sciences.

ORCID

Top concepts

Publications per year

2003–2023

10

Publications

10

Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER

Lars Sävendahl, Michel Polak, Philippe Backeljauw et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 51 citations · Full text

Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program

Lars Sävendahl, Michel Polak, Philippe Backeljauw et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 47 citations · Full text

Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635

Claudia Balducci, Marco Nurra, Alberto Pietropoli et al. · Psychopharmacology · 2003 · 42 citations

, , +13

Long-Term Effectiveness and Safety of Childhood Growth Hormone Treatment in Noonan Syndrome

Tilman Rohrer, Jennifer Abuzzahab, Philippe Backeljauw et al. · Hormone Research in Paediatrics · 2020 · 25 citations · Full text

Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study

Moris Angulo, M. Jennifer Abuzzahab, Alberto Pietropoli et al. · International Journal of Pediatric Endocrinology · 2020 · 23 citations · Full text

Rows per page

1–5 of 10